Search Results
Nov 18, 2025, 11:03 ET Inspire Medical Systems, Inc. (INSP) Faces Investor Suit Over Disastrous Inspire V Launch-- Hagens Berman
and onboarding criteria required prior to the purchase and implant of Inspire V." The company also said that, although Inspire V's CPT code was approved for Medicare patients, "software updates for claims submissions and processing did not take effect until July 1." This meant that
More news about: Hagens Berman Sobol Shapiro LLP
Nov 18, 2025, 10:30 ET ASUS Unveils Comprehensive Storage Solutions at SC25
VS320D-RS12Featuring active-active controller design with Intel® Xeon® processors, these systems provide enterprise-grade
More news about: ASUS Computer International
Nov 18, 2025, 09:00 ET Contextual Intelligence Becomes the New Standard for Exceptional Customer Experience in 2026
improving data and analytics. High-maturity firms track AI-driven metrics at triple the rate of low-maturity peers, including automation success rates (66% vs 21%). AI transparency has become a non-negotiable expectation, with consumers demanding clear
More news about: Zendesk, Inc.
Nov 18, 2025, 08:56 ET New Cornerstone Advisors Research Finds Community Banks and Credit Unions Only Halfway to Successfully Leveraging Their Data
analytics capabilities. Credit unions outperformed banks significantly in every functional area, scoring an average of 271 vs. 211, suggesting stronger data-driven cultures within the credit union sector. Larger financial institutions generally achieved
More news about: Cornerstone Advisors
Nov 18, 2025, 08:49 ET Crypto's Great Deception: 75% of "Decentralized" Currency Controlled by Centralized Giants
degen casino model" of speculative chaos. In this scenario, participants repeatedly mint and trade meme tokens as though playing a peer-vs-peer casino — chasing short-term wins where most tokens collapse to near-zero value. (6)
More news about: Dr. David Utzke
Nov 18, 2025, 08:36 ET Colling Media Wins Top Honors at 2025 Netty Awards for Knight Transportation Campaign
thinking to ensure the new domain wasn't just functional, but future-focused. Key results following launch (September 2024–June 2025 vs. prior period) included: +49.5% sessions +44.5% new users
More news about: Colling Media
Nov 18, 2025, 08:00 ET Vasa Therapeutics Granted FDA Fast Track Designation for VS-041, a Novel Investigational Treatment of Heart Failure with Preserved Ejection Fraction (HFpEF)
advance VS-041 through clinical development." VS-041 is an oral small molecule inhibitor of MMP-2 and -9 with a demonstrated ability to ameliorate the underlying fibroinflammation in preclinical models of HFpEF. In a Phase 1 clinical trial completed earlier this year, VS-041 was
More news about: Vasa Therapeutics
Nov 18, 2025, 08:00 ET Eisai to Present Data on Lecanemab Continued Treatment, Subcutaneous Initiation Dosing, and Real-World Experience at the 18th Clinical Trials on Alzheimer's Disease (CTAD) Conference
Societal Cost and Efficiency Comparison of Subcutaneous vs Intravenous Lecanemab for Early Alzheimer's Disease in the United States (P361)
More news about: Eisai Inc.
Nov 18, 2025, 08:00 ET Health~Holland Awards Another Innovative Research Grant for DNA Pol IIIC Inhibitors to Leiden University Medical Center and Acurx Pharmaceuticals
has been reached with EMA included details on Acurx's two planned international Phase 3 clinical trials, 1:1 randomized (designed as non-inferiority vs vancomycin), primary and secondary endpoints, sample size, statistical analysis plan and the overall registration safety database. With mutually consistent
More news about: Acurx Pharmaceuticals, Inc.
Nov 18, 2025, 07:51 ET Pivotal kidneyintelX.dkd Data Published in Diabetes Care, Considered the Leading Clinical Journal Worldwide in Diabetes
Superior Prediction vs. KFRE kidneyintelX.dkd outperformed the Kidney Failure Risk Equation (KFRE) in predicting kidney
More news about: Renalytix plc
Nov 18, 2025, 07:45 ET Kikoff Integrates Optimal Path™ Interactive Score Planner from Equifax
said Cynthia Chen, Founder and CEO of Kikoff. "Optimal Path offers deeply personalized plans that encourage more engagement and financial improvement vs. generic credit-building tools. No matter what a member's current financial situation is, Optimal Path is a true differentiator that can help our members
More news about: Equifax Inc.
Nov 18, 2025, 06:02 ET Deloitte 2026 Life Sciences and Health Care Outlook: Industry May Lose Billions in Revenue and Growth if Consumer Mandate Isn't Met
could lose up to $114.1 billion in potential revenue. The Consumer Mandate vs. Executive Priorities Consumers prioritize convenience, access, and affordability.
More news about: Deloitte LLP
Nov 18, 2025, 03:17 ET Chromologics raises €7 million to bring its natural colour ingredients closer to market
22 FEBRUARY 2022 Chromologics' CEO GERIT TOLBERG ON NATURAL VS ARTIFICIAL FOOD COLORANTS
More news about: Chromologics
Nov 18, 2025, 03:12 ET Chromologics raises €7 million to bring its natural colour ingredients closer to market
22 FEBRUARY 2022 Chromologics' CEO GERIT TOLBERG ON NATURAL VS ARTIFICIAL FOOD COLORANTS
More news about: Chromologics
Nov 17, 2025, 17:30 ET Supermicro demonstreert de toekomst van HPC-clusters en AI-infrastructuur tijdens Supercomputing 2025
volgende generatie, van cloud tot edge, aan te bieden aan onze wereldwijde klanten. Onze producten worden in eigen huis ontworpen en geproduceerd (in de VS, Asia en Nederland). Hierbij maken we gebruik van wereldwijde faciliteiten voor schaal en efficiëntie, geoptimaliseerd om de TCO te verlagen en de impact
More news about: Super Micro Computer, Inc.
Nov 17, 2025, 12:30 ET Energy Realism vs. Decarbonization: Is it an either-or choice?
all stakeholders." The session will discuss: Energy realism vs. decarbonization and the implications for fuels and technology Federal and California influence on current and future fuels
More news about: Engine Technology Forum
Nov 17, 2025, 11:58 ET Bariatric Surgery vs GLP-1 Medications like Ozempic or Mounjaro: Bariatric Surgeon Dr. David G. Davtyan of Weight Loss Surgery Los Angeles Weighs In on Real-World Results
multimedia:https://www.prnewswire.com/news-releases/bariatric-surgery-vs-glp-1-medications-like-ozempic-or-mounjaro-bariatric-surgeon-dr-david-g-davtyan-of-weight-loss-surgery-los-angeles-weighs-in-on-real-world-results-302617281.html
More news about: The Weight Loss Surgery Center Of Los Angeles
Nov 17, 2025, 11:31 ET d-Matrix and Andes Team on World's Highest Performing, Most Efficient Accelerator for AI Inference at Scale
RISC-V CPUs, we're bringing the next generation of generative AI inference to life." The partnership marks another milestone for RISC-V's entry into large-scale AI inference, pairing Andes' mature CPU IP and software ecosystem with d-Matrix's innovative chiplet-based 3DIMC architecture.
More news about: d-Matrix
Nov 17, 2025, 11:05 ET Methyl Methacrylate (MMA) Monomer Market Surges to USD 8.7 Billion by 2033, Propelled by 5.4% CAGR - Verified Market Reports®
retrofit plants or build parallel capacity; operational costs can be higher or lower depending on feedstock availability (e.g., ethylene derivatives vs. acetone). Medium-term advantages include simplified effluent handling, lower cyanide management costs, diminished community/regulatory liabilities, and
More news about: Verified Market Reports
Nov 17, 2025, 10:00 ET Saxena White P.A. Announces a Proposed Settlement in the Malibu Boats, Inc., Securities Litigation
Plaintiff, vs. MALIBU
More news about: Saxena White P.A.
Nov 17, 2025, 09:15 ET Research Teams Not Using AI are Four Times More Likely to Lose Organizational Influence
leaders fear layoffs due to AI vs. 15% of individual contributors 68% of leaders consider themselves synthetic data experts vs. 41% of individual contributors 84% of leaders have experimented with synthetic research vs. 68% of individual contributors
More news about: Qualtrics, LLC
Nov 17, 2025, 09:14 ET ESGFIRE Reinitiates Coverage on Canadian Fertilizer Innovator Replenish Nutrients, Highlighting Exclusive U.S. Licensing Strategy; Target Price CAD 0.44 (USD 0.31)
showed modest revenue growth and a surge in gross margins (≈30% on granules) after Beiseker upgrades. Adjusted EBITDA loss narrowed slightly (–$0.49M vs –$0.59M y/y). Management reiterated that Beiseker's ramp-up will drive profitability and that the pellet licensing pipeline (MJ, FUE) will add cash flow
More news about: Earthrenew
Nov 17, 2025, 07:00 ET Siolta Therapeutics Reports Positive Phase 2 Results from the ADORED Study
a 64% reduction in the risk of developing physician-diagnosed atopic dermatitis compared to placebo at one year after initiation of treatment (23.3% vs. 43.1%; OR = 0.36; 90% CI 0.20-0.66; n=158; p = 0.005). When all randomized infants, including those who received less than 1 year of treatment, were
More news about: Siolta Therapeutics
Nov 17, 2025, 06:30 ET Jones Soda Reports Third Quarter 2025 Results
financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Financial Summary vs. Year-Ago Quarter Revenue increased by 15% to $4.5 million compared to
More news about: Jones Soda Co.
Nov 17, 2025, 05:00 ET Consensus Launches AI-Powered Demo Automation Platform Built for Modern Marketing Teams
sales teams higher-quality, ready-to-buy leads. Early users have already reported a 6-8x higher conversion rate with these Product Qualified Leads (PQLs) vs traditional MQLs, demonstrating the platform's impact on both top-of-funnel lead generation and pipeline acceleration. "Modern
More news about: Consensus